Life Sciences Funding in View: 2025 Outlook

Top 10 Global VC Deals 2024

Deal Size (USD millions)

Current Business Status

Companies

Deal Date

VC Round Series Primary Industry

Deal Type HQ Location

Xaira Therapeutics 23-Apr-2024

$1,000

1st Round Series A Drug Discovery

Startup

Early Stage VC San Francisco, CA

Areteia Therapeutics

12-Feb-2024

$425.0

1st Round Series A1

Drug Discovery

Clinical Trials - Phase 3 Early Stage VC Chapel Hill, NC

Treeline Biosciences 19-Aug-2024

$421.8

3rd Round Series A Drug Discovery

Startup

Early Stage VC Watertown, MA

Kailera Therapeutics 01-Oct-2024

$400.0

1st Round Series A Drug Discovery

Clinical Trials - Phase 3 Early Stage VC Waltham, MA

Mirador Therapeutics Avenzo Therapeutics

Other Healthcare Technology Systems

21-Mar-2024

$400.0

1st Round Series A

Generating Revenue

Early Stage VC San Diego, CA

26-Mar-2024

$385.9

1st Round Series A Drug Discovery

Clinical Trials - Phase 2 Early Stage VC San Diego, CA

Formation Bio

26-Jun-2024

$372.0

5th Round Series D Drug Discovery

Generating Revenue

Later Stage VC New York, NY

Candid Therapeutics

20-Aug-2024

$370.0

1st Round Series B Drug Discovery

Clinical Trials - Phase 1

Early Stage VC San Diego, CA

35Pharma

26-Nov-2024

$350.0

2nd Round Series C Biotechnology

Clinical Trials - General

Later Stage VC Montreal, Canada

Metsera

26-Aug-2024

$350.0

1st Round Series A Drug Discovery

Clinical Trials - Phase 2 Early Stage VC New York, NY

Source: PitchBook Data, Inc.; *Data has not been reviewed by PitchBook analysts

7 / CUSHMAN & WAKEFIELD

LIFE SCIENCES JANUARY 2025